FDA Recall of Zantac Ranks As One Of The Most Important Human Health Developments of 2020

Heartburn pain from stress and anxiety is real and could cause cancer if left untreated

Monday, December 28, 2020 - 2020 was a year that saw millions of American small business owners thrust onto the ledge of bankruptcy and financial ruin, as state governments ordered restaurants, fitness clubs, and virtually all non-essential businesses to close their doors. The disruption caused many to experience panic and anxiety as the financial future became uncertain at best. Heartburn and indigestion are two symptoms of extreme stress caused by the lockdown. Americans scrambled for Zantac, their favorite brand of antacid and heartburn reliever, only to find empty store shelves. Zantac ranitidine was recalled by the Food and Drug Administration when elevated levels of NDMA were discovered in early 2020 and reported to the agency. Sanofi, the maker of Zantac, voluntarily recalled it, followed about a month later by the FDA recalling all ranitidine medicines. On April 1, 2020, according to the FDA, "The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity."

Millions of Americans may have died as a direct result of cancer that was allegedly caused by taking Zantac. As a result, thousands have filed lawsuits against Sanofi seeking more than an explanation as to why the company did not forewarn them of the cancer risk they faced from taking Zantac regularly and for many years. Zantac cancer litigation is in its infancy and there have been no trials to date. Experts think that once the first multi-million dollar jury award is awarded, tens of thousands more people with cancer may file. Since over 15 million Americans per year were taking Zantac at the time of the recall, some think Zantac cancer could become one of the largest mass tort legal actions ever undertaken, ranking up there with tobacco and Army Earplug hearing damage. Zantac lawyers stand ready to listen to your complaint free of charge or obligation to see if you have a case.

For the record, scientists have determined that ranitidine is inherently unstable and does not need an outside stimulus or contamination to make levels of NDMA escalate to carcinogenic levels. Both Sanofi and the FDA have known for decades that ranitidine contained NDMA but at levels thought low enough to be considered safe. If you or a loved one have relied on Zantac regularly for a long time you should see a physician for cancer screening. Lawsuits allege Zantac has caused cancer of the stomach, bladder, esophagus, prostate, colon and colorectal system, and even breast cancer.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.